Toll Free: 1-888-928-9744

Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Reviva Pharmaceuticals Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Reviva Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Reviva Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Reviva Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Reviva Pharmaceuticals Inc.'s pipeline products

Reasons to buy

- Evaluate Reviva Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Reviva Pharmaceuticals Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Reviva Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Reviva Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Reviva Pharmaceuticals Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Reviva Pharmaceuticals Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Reviva Pharmaceuticals Inc. Snapshot 5
Reviva Pharmaceuticals Inc. Overview 5
Key Information 5
Key Facts 5
Reviva Pharmaceuticals Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Reviva Pharmaceuticals Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Reviva Pharmaceuticals Inc. - Pipeline Products Glance 11
Reviva Pharmaceuticals Inc. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Reviva Pharmaceuticals Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Reviva Pharmaceuticals Inc. - Unknown Stage Pipeline Products 14
Unknown Products/Combination Treatment Modalities 14
Reviva Pharmaceuticals Inc. - Drug Profiles 15
RP-5063 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
RP-10000 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
RP-11000 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
RP-12000 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
RP-13000 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
RP-14000 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
RP-15000 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
RP-16000 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
RP-17000 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Reviva Pharmaceuticals Inc. - Pipeline Analysis 24
Reviva Pharmaceuticals Inc. - Pipeline Products by Target 24
Reviva Pharmaceuticals Inc. - Pipeline Products by Route of Administration 25
Reviva Pharmaceuticals Inc. - Pipeline Products by Molecule Type 26
Reviva Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 27
Reviva Pharmaceuticals Inc. - Recent Pipeline Updates 28
Reviva Pharmaceuticals Inc. - Dormant Projects 30
Reviva Pharmaceuticals Inc. - Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33
List of Tables
Reviva Pharmaceuticals Inc., Key Information 5
Reviva Pharmaceuticals Inc., Key Facts 5
Reviva Pharmaceuticals Inc. - Pipeline by Indication, 2014 8
Reviva Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9
Reviva Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10
Reviva Pharmaceuticals Inc. - Phase III, 2014 11
Reviva Pharmaceuticals Inc. - Preclinical, 2014 12
Reviva Pharmaceuticals Inc. - Discovery, 2014 13
Reviva Pharmaceuticals Inc. - Unknown, 2014 14
Reviva Pharmaceuticals Inc. - Pipeline by Target, 2014 24
Reviva Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 25
Reviva Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 26
Reviva Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 27
Reviva Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 28
Reviva Pharmaceuticals Inc. - Dormant Developmental Projects,2014 30 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify